Primerdesign is focused on the design, manufacture, validation and supply of real-time PCR kits and reagents for pathogen detection across a range of different applications.

Our mission is to enable our customers to improve health outcomes, ensuring food safety & integrity of supply chain and enhance the well-being of pets, animals and livestock by providing an extensive portfolio of qPCR products and delivering custom development services and solutions.

Primerdesign is part of the Novacyt Group. Novacyt is an international molecular diagnostics company providing a broad portfolio of integrated technologies and services, primarily focused on the delivery of genomic medicine. The company develops, manufactures, and commercialises a range of molecular assays and instrumentation to deliver workflows and services that enable seamless end-to-end solutions from sample to result across multiple sectors including human health, animal health and environmental.

The Company is divided into three business segments:

Clinical - Broad portfolio of human clinical in vitro diagnostic products, workflows and services focused on three therapeutic areas:

• Reproductive Health: NIPT, Cystic Fibrosis and other rapid aneuploidy tests

• Precision Medicine: DPYD genotyping assay

• Infectious Diseases: Winterplex, multiplex winter respiratory PCR panel

Instrumentation - Portfolio of next generation size selection DNA sample preparation platforms and rapid PCR machines, including:

• Ranger® Technology: automated DNA sample preparation and target enrichment technology
  
• MyGo: real-time quantitative PCR (qPCR) instruments
  
• Research Use Only - Range of services for the life sciences industry:
  
• Design, manufacture, and supply of high-performance qPCR assays and workflows for use in human health, agriculture, veterinary and environmental, to support global health organisations and the research industry
  
• Pharmaceutical research services: whole genome sequencing (WGS) / whole exome sequencing (WES)